Cargando…
SAT-410 Long Term Evaluation of TSH Receptor Antibodies and Thyroid Stimulating Immunoglobulin After Radioiodine Therapy for Thyrotoxicosis
Background Radioioactive iodine therapy (RAI) is an excellent choice to treat thyrotoxicosis, particularly Graves′ disease (GD) patients. After RAI therapy, it is well known that TSH receptor antibodies (TRAb) rise in GD patients and autoimmunity can eventually surge in patients with toxic multinodu...
Autores principales: | Marui, Suemi, Irigoitia, Bruna, Lenczuk, Aline, Rocha, Nelisa Helena, Brito, Luciana Pinto, Watanabe, Tomoco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207484/ http://dx.doi.org/10.1210/jendso/bvaa046.1301 |
Ejemplares similares
-
SAT-415 Clinical Performance of Thyroid-Stimulating Immunoglobulin for Graves′ Disease Diagnosis
por: Marui, Suemi, et al.
Publicado: (2020) -
MON-591 Thyroid Function and Autoimmunity Status after One and Three Months of Radioactive Iodine Therapy for Thyrotoxicosis
por: Irigoitia, Bruna, et al.
Publicado: (2019) -
SAT-614 False-Positive in Measurement of Thyroglobulin in a Patient with Mixed Connective Tissue Disease
por: Maciel, Ana Alice, et al.
Publicado: (2019) -
SAT460 Higher TSH Receptor Antibody At Diagnosis And Younger Age Predict Recurrence of Graves' Thyrotoxicosis After Thionamide Withdrawal At 10 Years
por: Wilson Gibb, Fraser, et al.
Publicado: (2023) -
SAT483 Role of Cholestyramine in Refractory Amiodarone-induced Thyrotoxicosis
por: Zhao, Huaying, et al.
Publicado: (2023)